Patent Legislation Highlights
Highlights | |
|
May 7, 2008 |
USPTO appeals Tafas v. Dudas decision. |
|
Apr 1, 2008 |
District Court grants Glaxo summary judgment; PTO proposed rules deemed improper. |
|
Feb 4, 2008 |
White House issues letter recommending the Senate reject the current form of the Act. |
|
Jan 14, 2008 |
Senate Judiciary Committee sends Senate version of Act to full Senate recommending passage. |
|
July 2007 |
U.S. House of Representatives passes its version of The Patent Law Reform Act of 2007. |
Details | |
|
May 7, 2008 |
USPTO appeals Tafas v. Dudas decision. Click here to read the appeal.. |
|
Apr 1, 2008 |
District Court grants Glaxo summary judgment; PTO proposed rules deemed improper. |
|
Feb 6, 2008 |
Paul Fleischut Is Quoted on Patent Reform Legislation - Senniger Powers Attorney Paul Fleischut discusses patent reform legislation in the January 28, 2008 issue of Chemical Week magazine. Mr. Fleischut says, "The impetus for the reform seems to be a desire to harmonize with the rest of the world and to simplify and eliminate litigation on the timing of one's invention." Organizations within the chemical industry differ in their support of such a change. The full article is here. |
|
Feb 5, 2008 |
Administration Recommends the Senate reject the current form of the Act - Letter |
|
Jan 16, 2008 |
U.S. Senate Judiciary Committee Approves Patent Law Reform Legislation - On January 14, 2008 the Committee issued a report urging the Senate to pass the Patent Reform Act of 2007 currently under consideration. The Act would fundamentally change the U.S. patent practice by converting it from a "first-to-invent" to a "first-to-file" system. The Act would also limit the manner in which compensatory damages may be calculated in infringement suits, and make procedural changes to the way patent lawsuits are pleaded and conducted. The bill will presumably be reconciled with a slightly different version which passed the House of Representatives last year by a close 220 to 175 margin. While the concept of reform has significant support in government and industry, the particular reforms under consideration have drawn substantial criticism. Debate in Congress is expected to be contentious, and passage is not a foregone conclusion. |